A 3-day-old term neonate born to a mother with prolonged rupture of membranes (PROM >18 hours) presents with fever, poor feeding, and lethargy. Blood culture is pending. Regarding the empiric antibiotic regimen for neonatal sepsis in this age group, all of the following are correct EXCEPT:

Explanation

## Empiric Antibiotic Therapy in Neonatal Sepsis ### Standard Regimen for Early-Onset Sepsis (EOS) **Key Point:** The gold standard empiric therapy for neonates ≤7 days old with suspected sepsis is **ampicillin + gentamicin** (or ampicillin + cefotaxime in some protocols). ### Why Each Component Matters | Antibiotic | Coverage | Rationale | |---|---|---| | Ampicillin | Listeria monocytogenes, Group B Streptococcus (GBS), Enterococcus | Listeria is a critical pathogen in neonates <7 days; cephalosporins do NOT cover it | | Gentamicin | Gram-negative organisms (E. coli, Klebsiella, Enterobacter) | Synergistic with ampicillin; excellent for aerobic gram-negatives | ### Why Cephalosporins Are NOT Monotherapy **High-Yield:** Third-generation cephalosporins (cefotaxime, ceftriaxone) have **poor Listeria coverage** (~10% of Listeria are resistant). They cannot be used as monotherapy in neonates <7 days because Listeria monocytogenes is a significant pathogen in this age group. **Clinical Pearl:** Cephalosporins may be used in combination with ampicillin in some centers (ampicillin + cefotaxime), but cephalosporins alone are inadequate and represent a critical gap in coverage. ### The Correct Answer Option 3 (cephalosporins as monotherapy) is **incorrect** because: 1. Cephalosporins lack reliable Listeria coverage 2. They cannot replace the ampicillin + gentamicin combination 3. Monotherapy increases risk of missing Listeria sepsis **Warning:** A common trap in clinical practice is assuming "broad-spectrum" cephalosporins cover all neonatal pathogens — they do not.